A1. Aynacioglu AS, Brockmöller J, Bauer S, Sachse C, Güzelbey P, Öngen Z, Nacak M, Roots I. Frequency of Cytochrome P450 CYP2C9 Variants in a Turkish Population and Functional Relevance for Phenytoin. Br J Clin Pharmacol. 48:409-415, 1999.

A2. Aynacioglu AS, Sachse C, Bozkurt A, Kortunay S, Nacak M, Schröder T, Kayaalp SO, Roots I, Brockmöller J. Low frequency of Defective alleles of Cytochrome P450 enzymes 2C19 and 2D6 in the Turkish Population. Clinical Pharmacology & Therapeutics. 66(2):185-192, 1999.

A3. Aynacioglu AS, Cascorbi I, Mrozikiewicz PM, Nacak M, Tapanyiğit EE, Roots I. Paraoxonase 1 Mutations in a Turkish Population. Toxicology and Applied Pharmacology. 157 (3): 174-177, 1999. doi:10.1006/taap.1999.8690.

A4. Aynacioglu AS, Bozkurt A, Nacak M, Kortunay S, Tunç R, Dincel A, Kayaalp SO. N-acetyltransferase polymorphism in patients with Behçet’s disease. Eur J Clin Pharmacol. 57:659-662, 2001.

A5. Erbagci AB, Tarakcioglu M, Aksoy M, Kocabas R, Nacak M, Aynacioglu AS, Sivrikoz C. Diagnostic value of CRP and Lp(a) in coronary heart disease. Acta Cardiol. 57(3):197-204, 2002.

A6. Nacak M, Aynacioglu AS, Filiz A, Cascorbi I, Erdal ME, Yilmaz N, Ekinci E, Roots I. Association between the N-acetylation genetic polymorphism and bronchial asthma. British Journal of Clinical Pharmacology. 54:671-674, 2002.

A7. Çataloluk O, Nacak M, Savaş HA, Tutkun H, Zoroğlu SS, Herken H, Barlas Ö, Özen MM, Arslan A. Angiotensin converting enzyme gene polymorphism and its association to bipolar affective disorder in Turkish Patients. Neurology, Psychiatry and Brain Research. 10(3):129-132, 2002.

A8. Ozkur M, Erbagci Z, Nacak M, Tuncel AA, Alasehirli B, Aynacioglu AS. Association of insertion/deletion polymorphism of the angiotensin-converting enzyme gene with psoriasis. Br J Dermatol. 51(4): 792-5, 2004.

A9. Ozkur M, Erbagci I, Gungor K, Nacak M, Aynacioglu S. Bekir NA. Angiotensin-converting enzyme insertion-deletion polymorphism in primary open-angle glaucoma. Ophthalmologica. 218(6): 415-8, 2004.

A10. Aynacioglu AS, Nacak M, Filiz A, Ekinci E, Roots I. Protective role of glutathione s-transferase PI (GSTPI) VaII05VaI genotype in patients with bronchial asthma. British Journal of Clinical Pharmacology. 57(2):213-217, 2004.

A11. Nacak M, Davutoğlu V, Soydinç S, Dinçkal H, Türkmen S, Erbağcı B, Akçay M, Aynacioglu AS. Association between angiotensin converting enzyme gene polymorphism and coronary artery disease in individuals of the South-Eastern Anatolian population. Anadolu Kardiyol Derg. 4:45-51, 2004.

A12. Ozkur M, Erbagci Z, Nacak M, Tuncel A, Gorucu S, Aynacioglu S. Association of the Arg16Gly polymorphism of the beta-2-adrenergic receptor with psoriasis. J Dermatol Sci. 35(2):162-4, 2004.

A13. Virit O, Herken H, Nacak M, Akyol O, Tutkun H, Savas HA, Yanık M, Namlı M. Schizophrenia and angiotensin converting enzyme gene association in Turkish patients. Neurology Psychiatry and Brain Research. 12(4): 153- 158, 2005.

A14. Sahan-Firat S, Tiftik RN, Nacak M., Buyukafsar K. Rho kinase expression and its central role in ovine gallbladder contractions elicited by a variety of excitatory stimuli. Eur J Pharmacol. 528(1-3): 169-175, 2005.

A15. Alasehirli B, Cekmen M, Nacak M., Balat A. Effects of caffeine on placental total nitrite concentration: A 21-day, vehicle-controlled study in rats. Current Therapeutic Research. 66(2): 130-137, 2005.

A16. Davutoglu V, Nacak M. Influence of Angiotensin-converting Enzyme Gene Insertion/Deletion Polymorphism on Rheumatic Valve Involvement,Valve Severity and Subsequent Valve Calcification. The Journal of Heart Valve Disease. 14: 277-281, 2005.

A17. Nacak M, Erbagci Z, Aynacioglu AS. Human arylamine N-acetyltransferase 2 polymorphism and susceptibility to allergic contact dermatitis. The International Journal of Dermatology. 45: 323-326, 2006.

A18. Nacak M, Erbagci Z, Buyukafsar K, Yurtsever AS, Tiftik RN. Association of Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism with Allergic Contact Dermatitis. Basic & Clinical Pharmacology & Toxicology. 101:101–103, 2007.

A19. Baransel Isir A, Oguzkan S, Nacak M, Gorucu S, Dulger E, Arslan A. The COMT Val158Met polymorphism and susceptibility to cannabis dependence. Am J Forensic Med Pathol. 29(4): 320-322, 2008.

A20. Isir AB, Dai AI, Nacak M, Gorucu S. Study: the lack of significant association of the catechol-O-methyl transferase (COMT) gene polymorphism in violent offenders with mental retardation. J Forensic Sci. 55(1):225-228, 2010.

A21. Nacak M, Nacak I, Sanli M, Ozkur M, Pektaş M, Aynacioğlu AS. Association of angiotensin converting enzyme gene insertion/deletion polymorphism with lung cancer in Turkey. Cancer Genet Cytogenet. 198(1):22-26, 2010.

A22. Dogulu F, Özkur M, Dikensoy E, Nacak M, Benlier N, Aynacioglu AS. Association of Gln27Glu polymorphism of the β2-adrenergic receptor with preeclampsia. African Journal of Biotechnology. 10(19): 3689-3694, 2011.

A23. Benlier N, Erdogan M, Özkur M, Yildiz O, Nacak M, Yamak B, Aynacioglu AS. Association of E23K polymorphism of Kir6.2 gene with coronary artery disease. African Journal of Pharmacy and Pharmacology. 5(4): 554-558, 2011.

A24. Nacak M, Baransel Isir A, Oguzkan Balcı S, Pehlivan S, Benlier N, Aynacioglu AS. Analysis of Dopamine D2 receptor (DRD2) gene polymorphisms in cannabinoid addicts. Journal of Forensic Sciences. 57(6):1621-4, 2012.

A25. Col Araz N, Nacak M, Oguzkan Balci S, Benlier N, Araz M, Pehlivan S, Balat A, Aynacioglu AS. Childhood obesity and the role of dopamine D2 receptor and Cannabinoid Receptor-1 Gene Polymorphisms. Genet Test Mol Biomarkers. 16(12):1408-12, 2012. doi: 10.1089/gtmb.2012.0244. Epub 2012 Oct 11.

A26. Oguzkan-Balci S, Col-Araz N, Nacak M, Araz M, Sabanci H, Balat A, Pehlivan S. Mitochondrial uncoupling protein 2 (UCP2) gene polymorphisms are associated with childhood obesity and related metabolic disorders. J Pediatr Endocr Met 2013;26(3-4):277-83. doi: 10.1515/jpem-2012-0267.

A27. Ozdemir V, Endrenyi L, Aynacıoğlu S, Bragazzi NL, Dandara C, Dove ES, Ferguson LR, Geraci CJ, Hafen E, Kesim BE, Kolker E, Lee EJ, Llerena A, Nacak M, Shimoda K, Someya T, Srivastava S, Tomlinson B, Vayena E, Warnich L, Yaşar U. Bernard Lerer: recipient of the 2014 inaugural Werner Kalow Responsible Innovation Prize in Global Omics and Personalized Medicine (Pacific Rim Association for Clinical Pharmacogenetics). OMICS. 18(4):211-21, 2014.

A28. Baransel Isir A, Nacak M, Oguzkan Balci S, Pehlivan S, Kul S, Benlier N, Aynacioglu AS. Relationship between the 1359 G/A polymorphism of the Central Cannabinoid Receptor 1 (CNR1) gene and susceptibility to cannabis addiction in a Turkish population. Australian Journal of Forensic Science. 47(2): 230-238, 2015. DOI: 10.1080/00450618.2014.936895

A29. Col Araz N, Nacak M, Oguzkan Balci S, Pehlivan S, Balat A. A Preliminary Study of the Possible Role of Cannabinoid Receptor-1 (CNR1) Gene Polymorphisms in the Development of Morbid Obesity in Obese Children. J Clin Res Pediatr Endocrinol 2015; 7: 87-87

A30. Col Araz N, Oguzkan Balci S, Nacak M, Balat A, Pehlivan S. The Possible Role of Mitochondrial Uncoupling Protein 2 (UCP2) Gene on the Development of Metabolic Syndrome and Platelet Count in Obese Children/Adolescents - A Preliminary Study. J Clin Res Pediatr Endocrinol 2015; 7: 66-66.

A31. Baransel Isir A, Nacak M, Oguzkan Balci S, Aynacioglu AS, Pehlivan S. Genetic contributing factors to substance abuse: an association study between eNOS gene polymorphisms and cannabis addiction in a Turkish population. Australian Journal of Forensic Sciences 2016; 48 (6): 676-683. DOI: 10.1080/00450618.2015.1112428

A32. Baransel Isir A, Baransel C, Nacak M. An Information Theoretical Study of the Epistasis Between the CNR1 1359 G/A Polymorphism and the Taq1A and Taq1B DRD2 Polymorphisms: Assessing the Susceptibility to Cannabis Addiction in a Turkish Population. J Mol Neurosci 2016; 58: 456-460. DOI 10.1007/s12031-016-0721-z